IRRAS Receives FDA Clearance for IRRAflow® in the US
IRRAflow is a transformative medical device that combines controlled irrigation with ongoing fluid drainage for the treatment of patients with intracranial bleeding Plans to launch IRRAflow in the US underwayStockholm, Sweden, July 16, 2018 – IRRAS AB (NASDAQ Stockholm: IRRAS), a commercial-stage medical technology company focused on developing and commercializing transformative treatments to manage intracranial fluids, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for IRRAflow, its integrated, closed medical device system that enables